—> AXXE is December’s 1st Big Technical Alert! (A Winning Formula)

Recommended Stock Newsletters
 
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

StockRunway Newsletter

Good Evening Everyone, My latest pick has just upped the ante in the muscle supplements space and in doing so, created a massive opportunity for trading profits let alone a previous massive winner! The company has announced plans to expand its retail presence in 2015 and is in negotiations with a leading marketing firm to make sure things go off without a hitch.

The company has also announced approval for the sale of its high potency Omega-3 fish oil supplement in Canada, a move that certainly brings the company into the big-dollar conversation.

Muscle supplements and pain combined are worth more than $60 billion annually so there is little doubt that the company`s growth potential is based on solid foundations. There is little doubt about its technical setup too. The stock is trading just north of the .15 level after several pullbacks…yet liquidity levels are starting to build once again right now.

This is a very healthy stock right now it seems and it has all the right holiday decorations for a breakout. Move on it ASAP and start your research immediately.

► December`s 1st Big First Class Alert:

► Axxess Pharma, Inc. – Ticker: AXXE AXXE has Pure Breakout Potential – The company has strategic aspirations:

1. AXXE is expanding its product base and its geographical reach. Approval from Health Canada for its Omega-3 fish oil supplements highlights the company`s drive to expand.

2. AXXE and its TapouT line of supplements are starting to gain serious traction and have the potential to become one of the leading products in its industry sector.

More About Axxess Pharma, Inc:

AXXE (Axxess Pharma Inc.) is a pharmaceutical company, engages in the marketing and distribution of various pharmaceutical products and diagnostic medical devices in Canada and internationally.

AXXE distributes dermatological, therapeutic nutritional, pain management, and diagnostic products. AXXE`s principal product line includes its TapouT branded line of muscle supplements and pain relief supplements. The company also distributes products that target Dermatology, Rheumatology, Gynecology, Urology and Nephrology markets.

AXXE distributes its products through physicians, hospitals, government and defense institutions, and pharmacies. AXXE was founded in 1997 and is headquartered in Markham, Canada.

AXXE Receives Health Canada Approval to Sell High Potency Omega-3 Fish Oil Supplement throughout Canada AXXE said that its Omega-3 fish oil will be sold under the globally recognized TapouT brand name.

According to the release, AXXE has now received Health Canada approval to sell their high potency Omega-3 fish oil supplement throughout Canada. The Omega-3 fish oil will be sold under the globally recognized TapouT name with all revenues flowing directly into Axxess Pharma, Inc.

The company anticipates generating significant residual sales from the $1 billion Canadian Omega-3 oil market.

You can read the full news source covering the big announcement here:

http://clicks.aweber.com/y/ct/l=4k3kt&m=3lkOrC_v7n976pl&b=SXk1FyBRe9NLL1RvxoqMBQ AXXE: Is this the Start of a Big December Rally Ahead AXXE`s chart shows that momentum and upside potential are driving forces into its current setup: http://clicks.aweber.com/y/ct/l=4k3kt&m=3lkOrC_v7n976pl&b=URr5in_CTC8_yQmyK2_bxA AXXE has very strong bounce potential and RSI is just 33. The oversold setup shows just how undervalued the stock is at current levels.

The stock is providing investors and traders with plenty of volatility as intra-day swings are becoming more and more pronounced.

All of which has helped to keep the stock on an upward trajectory via investor interest while confidence and healthy volume has laid the foundations for a potential breakout.

Strong trading has pushed AXXE to a 12-month high of .50. The stock is poised to potentially break those levels on current news and technicals.

AXXE is trailing its 50 DMA by .02, a clear marker that current valuation is discounted.

News of any further potential expansion could prove to be massive hence the company`s relatively mid-size, yet giving it an enormous boost and act as a major catalyst over the near term.

Position oneself accordingly…I am urging all members to begin your research right away on this technical play and be ready for the action tomorrow morning! The Crew Chief www.StockRunway.com info@StockRunway.com Copyright 2010 StockRunway.com All Rights Reserved. Protected by copyright laws of the United States and international treaties.

This email may only be used pursuant to the subscription agreement controlling use of the StockRunway financial web site and any reproduction, copying, or redistribution of this email or its contents, in whole or in part, is strictly prohibited without the express written permission of StockRunway.com.

LEGAL DISCLAIMER: Neither StockRunway nor any of its employees are registered investment advisors or a Broker/Dealer. As such, StockRunway does not offer or provide personalized investment insight. Although StockRunway may answer general customer service questions, they are not licensed under securities laws to address your particular investment situation. Nothing in this report, nor any communication by our employees to you should be considered personalized investment insight.

This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

StockRunway.com is often times compensated to feature certain companies. These third party, may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.

Release of Liability: Through use of this website viewing or using you agree to hold StockRunway.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.

StockRunway.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockRunway.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead StockRunway.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks.

Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.

StockRunway.com is compliant with the Can Spam Act of 2003.

StockRunway.com does not offer such advice or analysis, StockRunway.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor`s investment may be lost or impaired due to the speculative nature of the companies profiled.These are paid advertisements used to generate exposure and awareness about the company or companies mentioned in our newsletters.

For full disclaimer please visit our website:

http://clicks.aweber.com/y/ct/l=4k3kt&m=3lkOrC_v7n976pl&b=HdvOYHvHI10vAaONNZbw4w Our Ace Pilot lives by one simple measure of success…Yours! 4940 Merrick Rd. Suite 128 Massapequa Park, New York 11758 To

 
This entry was posted in StockRunway and tagged . Bookmark the permalink.

Comments are closed.